COVID Moonshot Consortium Unveils Crowd-Sourced Covid Antiviral Lead Compound

The work of the COVID Moonshot Consortium is being published in the prestigious journal Science on 10 November, revealing their discovery of a potent SARS-CoV-2 antiviral lead compound. It also reflects on the success of its open science approach in launching a patent-free antiviral discovery program to rapidly develop a differentiated lead in response to

Read More


November the 10th Updated living WHO guideline on drugs for covid-19

November the 10th a panel of international experts representing the World Health Organization’s Guideline Development Group has updated its guidance on treatments for patients with COVID-19. The new recommendations published by The BMJ are part of a living guideline, developed by the World Health Organization with the methodological support of MAGIC Evidence Ecosystem Foundation, to provide up

Read More


New Study: Gargling and Nasal Rinsing with Salt Water May Help Prevent Covid Hospitalization

Hospitalization rates in people with saline regimens significantly lower than in reference population  As Covid and its health effects move into a fourth year, those who become infected may be searching for remedies to improve their respiratory symptoms and keep them out of the hospital. A new study being presented at this year’s American College

Read More


Convalescent plasma reduces mortality by 10% in Covid-19 patients in acute respiratory distress and on artificial respiratory assistance

In a study published in The New England Journal of Medicine, clinicians and researchers from the CHU of Liège and the University of Liège show that the administration of plasma taken from convalescent donors after infection with Sars-CoV-2 to patients suffering from acute respiratory distress syndrome requiring artificial mechanical ventilation significantly reduced mortality (10%). he randomised

Read More


Businesses marketing unproven expensive stem cell treatments and exosome therapies for COVID-19 and Long Covid

Researchers have identified 38 businesses engaged in direct-to-consumer marketing of purported stem cell treatments and exosome therapies for preventing and treating COVID-19 even though these “interventions” have not been approved or authorized by national regulatory bodies and are not supported by convincing safety and efficacy data. The analysis, appearing in the journal Stem Cell Reports, also found

Read More